BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2007
View Archived Issues
Chloroquine to be evaluated for the treatment of metabolic syndrome / News in Context
Read More
Anxiety treatment with tandospirone improves atopic dermatitis
Read More
New targeted topical cream treatment shows promise in preclinical models of psoriasis
Read More
New therapeutic agents for renal-urological disorders disclosed in recent patents
Read More
Novel agents for treating neurological disorders revealed in patent literature
Read More
Recent patents describe possible new treatment options for diabetes
Read More
Quest Group International acquires new oncology product candidates
Read More
Phase III program planned for bapineuzumab in Alzheimer's
Read More
FDA awards orphan drug status to Ardana's oral growth hormone secretagogue
Read More
CUV-1647 begins phase III study in polymorphic light eruption
Read More
Tripep prepares for phase I/II study of ChronVac-C
Read More
Early close for tibolone study in breast cancer
Read More
Helsinn supports safety of nimesulide
Read More
New study compares safety of drug-eluting stents
Read More
KineMed evaluates mechanism of action of colesevelam in type 2 diabetes
Read More
CytRx updates operational activities
Read More
Talabostat clinical program placed on hold
Read More
CMC Biopharmaceuticals to support development of MORAb-028
Read More
Domain antibody PN-0621 begins phase I trial
Read More
MyVax studied in follicular NHL in phase II trial
Read More
AD-923 successfully completes pharmacokinetic study
Read More
Antigenics offers summary of Q1 events
Read More
Faster and prolonged acid suppression with AGN-201904-Z, an omeprazole prodrug
Read More
Amoxicillin PULSYS NDA accepted for filing
Read More
Lybrel receives FDA approval
Read More